Our European Special Interest Groups (SIGs) sponsored by EFSPI and PSI are playing a key role and foster connections across disciplines, industry, academia and countries/regions. The SIGs provide a forum for members to discuss topics of mutual interest, keep updated on developments in a particular area of the industry, to organise events on their specialist field and/or to collaborate on developing the science of that field. Our current SIGs cover a wide range of topics as set out below. We also have a working party looking at the statistical implications of greater clinical trial data sharing and a group of volunteers providing a statistical briefing service on health stories in the lay media.

• AI and ML
• AIMS
• Benefit-Risk
• Biomarkers
• Causal Inference
• CMC Statistical Network Europe
• CSM/QTL
• Data Science
• Data Sharing
• Decision Making
• Early Phase
• Historical Data
• HTA
• Launch & Lifecycle
• Medical Devices
• Multi-Component Endpoints
• Neuroscience-Estimands
• Oncology-Estimands
• Patient-Focused Drug Development
• Pre-clinical
• Randomisation
• Regulatory
• RWD
• Small Populations
• Software Engineering
• Treatment Effect Heterogeneity
• Vaccines
• Visualisation

For further information on any of the SIGs, take a look at their pages on the PSI website, or for general enquiries please contact Angela McPartlane PSI Board SIG liaison lead or Emmanuel Pham EFSPI SIG liaison. 

For additional information have a look at the new updated Operating Guideline:

44. European Special Interest Groups – final draft-26nov25